These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3001841)

  • 1. Analysis of the dual mechanism of ACTH release by arginine vasopressin and its analogs in conscious rats.
    Mormède P; LeMoal M; Dantzer R
    Regul Pept; 1985 Nov; 12(3):175-84. PubMed ID: 3001841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA; Holmes MC; Makara GB; Kárteszi M; László FA
    Peptides; 1984; 5(3):519-22. PubMed ID: 6089144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
    Pierson PM; Guibbolini ME; Lahlou B
    J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the receptors which mediate the stimulation of ACTH secretion by vasopressin in conscious dogs.
    Schwartz J; Reid IA
    Neuroendocrinology; 1986; 42(2):93-6. PubMed ID: 3005898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis.
    Buckingham JC
    J Endocrinol; 1987 Jun; 113(3):389-96. PubMed ID: 3040881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs.
    Knepel W; Homolka L; Vlaskovska M; Nutto D
    Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel type of vasopressin receptor on anterior pituitary corticotrophs?
    Baertschi AJ; Friedli M
    Endocrinology; 1985 Feb; 116(2):499-502. PubMed ID: 2981663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
    Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
    J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vasopressin receptor antagonist dPTyr (Me) AVP does not prevent stress-induced ACTH and corticosterone release.
    Mormède P
    Nature; 1983 Mar 24-30; 302(5906):345-6. PubMed ID: 6300679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin and oxytocin reduce plasma prolactin levels of conscious rats in basal and stress conditions. Study of the characteristics of the receptor involved.
    Mormede P; Vincent JD; Kerdelhue B
    Life Sci; 1986 Nov; 39(19):1737-43. PubMed ID: 3022094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
    Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
    J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CRF and ANG II on ACTH and vasopressin release in conscious dogs.
    Klingbeil CK; Keil LC; Chang D; Reid IA
    Am J Physiol; 1988 Jul; 255(1 Pt 1):E46-53. PubMed ID: 2839038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively.
    Link H; Dayanithi G; Föhr KJ; Gratzl M
    Endocrinology; 1992 Apr; 130(4):2183-91. PubMed ID: 1312449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rat corticotrophin-releasing factor, arginine vasopressin and oxytocin on the secretions of adrenocorticotrophic hormone and corticosterone in the fetal rat in late gestation: in vivo and in vitro studies.
    Deloof S; Montel V; Chatelain A
    Eur J Endocrinol; 1994 Mar; 130(3):313-9. PubMed ID: 8156107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
    Familari M; Smith AI; Smith R; Funder JW
    Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary.
    Schwartz J; Derdowska I; Sobocinska M; Kupryszewski G
    Endocrinology; 1991 Aug; 129(2):1107-9. PubMed ID: 1649739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of corticotropin-releasing factor, arginine vasopressin and oxytocin on the polymorphism of plasma adrenocorticotropic hormone in the rat fetus in late pregnancy.
    Deloof S; Chatelain A; Leprêtre A
    Biol Neonate; 1994; 65(5):331-9. PubMed ID: 8054402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.